We are a not-for-profit organization of pharmaceutical and biotechnology companies with the mission of advancing science and technology to augment the capability of member companies to develop transformational solutions that benefit patients, regulators and the broader R&D community.
September 2021
Remember to register for the September 17 "Patient-centric Sampling Opportunities & Challenges for Implementation in Drug Development Programs" Symposium
September 2021
IQ Consortium invites you to register for the Predictive Dissolution Models for Real-time Release Testing: Development and Implementation Virtual Workshop taking place 11-12 November 2021.
August 2021
The IQ DruSafe Leadership Group and EFPIA publish the results from their collaborative survey on photosafety evaluation of pharmaceuticals after implementation of ICH S10.
Predictive Dissolution Models for Real-time Release Testing: Development and Implementation Workshop
November 11, 2021 - November 11, 2021
Workshop in Virtual
IQ Webinar: Use of CSTDs by Canadian Oncology Healthcare Providers & Exposure Risk to mAbs
October 22, 2021
Webinar in Virtual
IQ Webinar: Nanomedicine Development: Physicochemical Characterization Consideration
October 28, 2021
Webinar in Virtual